Efficient production of high specific activity 64Cu using a biomedical cyclotron
about
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myelomaDetection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPETCerebral blood flow quantification in the rat: a direct comparison of arterial spin labeling MRI with radioactive microsphere PET.Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.The copper radioisotopes: a systematic review with special interest to 64Cu.Phase 1 Evaluation of [(64)Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors.Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic miceNucleic Acid-directed Self-assembly of Multifunctional Gold Nanoparticle Imaging Agents.Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapySynthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imagingStroma targeting nuclear imaging and radiopharmaceuticals.Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsMetallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragmentCu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides.Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyCopper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Chelators for copper radionuclides in positron emission tomography radiopharmaceuticalsMolecular imaging with copper-64 in the drug discovery and development arena.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.Investigation of a vitamin B12 conjugate as a PET imaging probe.Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET.Copper import in Escherichia coli by the yersiniabactin metallophore system.Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.A purification system for (64)Cu produced by a biomedical cyclotron for antibody PET imaging.Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.Somatostatin analogues labeled with copper radioisotopes: current status.Development and preclinical studies of 64Cu-NOTA-pertuzumab F(ab')2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT.Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA.64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.Development of novel radionuclides for medical applications.
P2860
Q27316139-E104B681-FCD3-4837-8F4F-9F81DDFAA816Q28487987-24B0952C-B874-426A-9A10-F4FE04A0114DQ30565866-C9E55693-6B7E-4155-8D4A-EE5FFCB6AAB9Q33335764-3C5AAA4E-5A22-44D3-945E-3901D5D4A722Q33661508-3C40EBFB-986C-4D3F-B6A2-913350099ECAQ33887412-6B65F269-8BBB-496D-8B00-BD038383E50BQ34016136-C6540727-6123-4FF2-8B57-E52BA9E9ACF6Q34196254-E581D1B4-2947-426A-A5E4-D7CDF2268374Q34995186-7A9CAEEF-D5F0-4C92-8942-97038FFCD0BEQ35124411-5FC1FB71-505B-4342-B9F4-14B3932119EAQ35565660-2B2F486C-93DD-4B75-AF14-21A40231FD36Q35831439-0A6EE3BB-8C2C-4163-9361-DDD8BBF24C1DQ35881265-90D1A12A-D02F-4DE6-B1D0-5175D8FB02EDQ35999606-3E80AE00-83AA-4653-9243-E61171C0123EQ36291655-5717A400-8C2F-487B-984C-8BB543A69EB4Q37026964-9CDA81DC-BF8A-49B7-A0DA-028ADEF5A5EFQ37172093-15B904D4-9CF5-482D-8E4D-0866A3CB6694Q37230505-1E20CB62-0300-488A-9804-2310286C64D7Q37545575-31EC7DEB-ABAA-424A-A5C8-45D13C00375DQ37689802-7F72625A-183F-49DE-96A3-4CCD9E464853Q37853427-B760A41B-F259-4604-961A-55F1C07546EBQ37869905-93B5C48C-F304-46FD-916A-623EE35708F6Q38172069-FC2FEB9C-B574-4AEA-AA86-2A1BFED25200Q38448424-DE300BB7-CFC9-496E-96D4-CBC999CD5CC7Q38729041-465EED56-BF54-4B0D-9CBD-C12E80ADAB4CQ38846349-41F9094D-E107-4D4E-B2F8-9BEB6ECEB774Q39002153-384D8135-AAF7-42EA-9CD3-81B51AFF2FF7Q39017235-E7BB41D4-FB0E-477C-A085-B4567F4AF6C5Q39162754-EF7C3E56-44F8-46DF-9623-3506E2D63A72Q39729571-F6AAB0AF-2742-4B09-BC15-6E4A3FBA3439Q40113297-5BA93C02-8CAA-4AC4-9B71-D9769692AE65Q40271360-2187ECA0-C039-44AD-B083-E82071840B35Q40679496-5914D008-4CA2-4063-9238-CA8755523A13Q40925736-C20D7DC7-0FDF-48B8-B1E3-AE850CBA2EE9Q42133416-1258BC80-A75C-4B6A-A8A0-84018E1EC60FQ43019940-F6FA7EFA-93E2-4AB0-8918-4CC392A1AE37Q43376047-5F3305B4-ED41-41D2-B2B6-D58297D6CF73Q44140120-BE873A79-C4F1-4C73-9EC5-C6301430FEE3Q44967312-1C45AFBB-416F-4A1E-AE26-9B5E924D527AQ47645039-65DDD30C-4B8E-4715-B10F-5272431860E6
P2860
Efficient production of high specific activity 64Cu using a biomedical cyclotron
description
article
@en
im Januar 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1997
@uk
ലേഖനം
@ml
name
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@en
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@nl
type
label
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@en
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@nl
prefLabel
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@en
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@nl
P2093
P1476
Efficient production of high specific activity 64Cu using a biomedical cyclotron
@en
P2093
C S Cutler
D W McCarthy
R E Klinkowstein
R E Shefer
W H Margeneau
P356
10.1016/S0969-8051(96)00157-6
P577
1997-01-01T00:00:00Z